Related Experiment Video
Updated: Oct 19, 2026

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change
A W Blume1, J M Davis, K B Schmaling
1Department of Psychiatry, Harborview Medical Center, University of Washington, Seattle, USA. awblume@u.washington.edu
Abstract:
Substance abuse has been associated with cognitive dysfunction, such as problems with attention, reasoning, and memory. Certain psychiatric disorders also have been associated with cognitive difficulties, thus placing dually-diagnosed patients at high risk for cognitive impairment that could interfere with successful entry into or completion of therapy. Twenty-two dually-disordered inpatients were administered the Brief Readiness to Change Questionnaire to measure levels of motivation to change substance use, and a neuropsychological test battery that included the Wechsler Adult Intelligence Scale-Revised (WAIS-R), the Halstead Category Test (HCT), and the Wechsler Memory Scale-Revised (WMS-R). Higher general intellectual, executive, and memory functioning were significantly related to greater scores in readiness to change substance abuse in this sample. Cognitive ability may be an important variable to consider in the motivation and treatment of dually-diagnosed patients.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Therapeutic Drug Monitoring: Affecting Factors
Alzheimer's Disease: Treatment
Alzheimer Disease l: Introduction
Dementia l: Introduction